Introduction of health service initiatives that aim to either prevent or diagnose cancer early. These include vaccinations (e.g. the HPV vaccination), screening (e.g. the breast, cervical and colorectal screening programmes) and diagnostic tests (e.g. PSA testing for prostate cancer).
Monitoring trends in cancer incidence is essential if high quality cancer services are to be maintained and resourced. Trends for all cancers (excluding NMSC) along with the most common cancers are analysed in detail. Additionally projections of cancer incidence up to the year 2035 are presented for the first time in Northern Ireland.
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PROJECTED CHANGE IN INCIDENCE RATES BY SEX AND TYPE
Compared to the 2009-2013 average male incidence rates are projected to: -decrease by more than 20% by 2035 for stomach, bladder and prostate cancers, -increase by more than 20% by 2035 for melanoma, oral, liver and kidney cancers.
Also compared to the 2009-2013 average female incidence rates are projected to: -decrease by more than 20% by 2035 for stomach and cervical cancers; -increase by more than 20% by 2035 for melanoma, oral, uterine, liver, kidney, pancreatic, lung and breast cancer.
PROJECTED NUMBER OF CASES DIAGNOSED FROM 2015 TO 2035
In 2009-2013 there were 4,347 male and 4,275 female cases of cancer (ex. NMSC) diagnosed each year.
By 2020 the number of cases is expected to rise by 25% for men and by 24% for women to 5,443 male and 5,285 female cases.
By 2035 the number of cases is expected to rise by 65% for men and by 63% for women to 7,181 male and 6,967 females cases. 
Cases per year (prediction interval)
Cases per year (prediction interval) Cases per year (prediction interval) All (ex. NMSC) 4,425 5,443 (5140, 5746) 7,181 (6675, 7687) 4,351 5,285 (5050, 5520) 6,967 (6590, 7344) Bladder 150 169 (128, 210) 205 (162, 248) 61 67 (47, 87) 83 (62, 104) Brain 81 94 (67, 121) 110 (76, 144) 55 63 (42, 84) 75 (49, 101) Breast Kidney 173 244 (195, 293) 368 (294, 442) 115 161 (124, 198) 246 (189, 303) Leukaemia 116 137 (101, 173) 170 (128, 212) 80 91 (66, 116) 116 (88, 144) Liver 72 110 (77, 143) 179 (125, 233) 31 43 (24, 62) 67 (33, 101) Lung 649 816 (717, 915) 1,128 (991, 1265) 484 641 (570, 712) 923 (821, 1025) Melanoma 138 215 (168, 262) 370 (288, 452) 181 239 (193, 285) 317 (244, 390) NHL 175 226 (182, 270) 316 (257, 375) 150 180 (146, 214) 232 (191, 273) Oesophagus 127 163 (124, 202) 215
